Listed

Coty Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 7, 2015 and accepted by EDGAR at May 7, 2015, 17:05 ET.

Share

Management's discussion and analysis

As filed, 100,651 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2014 (“Fiscal 2014 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. The following discussion contains forward-looking statements. See Part II — Item 1A. Risk Factors of our Fiscal 2014 Form 10-K for a discussion on the uncertainties, risks and assumptions associated with these statements, as well as any updates to such discussion as may be included in subsequent reports we file with the SEC. Actual results may differ materially from those contained in any forward-looking statements. The following discussion includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.

All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.

OVERVIEW

We are a leading global beauty company. We manufacture and market beauty products in the Fragrances, Color Cosmetics and Skin & Body Care segments with distribution in over 130 countries and territories across both prestige and mass markets. We continue to operate in a challenging market environment particularly in mass fragrance in Western Europe and the U.S. We are focused on growing our ten power brands around the world through innovation, strong support levels and excellence in market execution. With respect to our non-power brands, we expect to see a gradual decline of those brands which are later in their lifecycle. We are also focused on expanding our geographic footprint into emerging markets and diversifying our distribution channels within existing geographies to increase market presence. As part of our expansion efforts, we entered into agreements to broaden distribution in Asia, South Africa, Brazil, the United Kingdom (“U.K.”), United Arab Emirates (“U.A.E.”) and Kingdom of Saudi Arabia (“K.S.A.”) during fiscal 2014 and 2015 and our results from certain of these efforts reflect incremental net revenues from joint venture consolidations and conversion from third party to direct distribution in these geographies.

We have determined that our operating and reportable segments are Fragrances, Color Cosmetics and Skin & Body Care (also referred to as “segments”). The reportable segments also represent our product groupings. During the three months ended September 30, 2014, in conjunction with the Organizational Redesign restructuring program (see Note 4, “Restructuring Costs” in Item 1, “Condensed Consolidated Financial Statements”), we reclassified revenues and costs associated with a brand from Fragrances to Skin & Body Care operating segment. This change has been reflected in each reporting period presented, both in the segment results below and in Note 6, “Goodwill and Other Intangible Assets, Net” in Item 1, “Condensed Consolidated Financial Statements”.

Non-GAAP Financial Measures

Adjusted Operating Income, Adjusted Income Before Income Taxes, Adjusted Net Income Attributable to Coty Inc. and Adjusted Net Income Attributable to Coty Inc. per Common Share are non-GAAP financial measures which we believe better enable management and investors to analyze and compare the underlying business results from period to period.

These non-GAAP financial measures should not be considered in isolation, or as a substitute for or superior to, financial measures calculated in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of our business as determined in accordance with GAAP. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis, and we provide reconciliations from the most directly comparable GAAP financial measures to the non-GAAP financial measures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Adjusted Operating Income, Adjusted Income Before Income Taxes, Adjusted Net Income Attributable to Coty Inc. and Adjusted Net Income Attributable to Coty Inc. per Common Share provide an alternative view of performance used by management and we believe that an investor’s understanding of our performance is enhanced by disclosing these adjusted performance measures. In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these adjusted performance measures. The following are examples of how these adjusted performance measures are utilized by management:

  • senior management receives a monthly analysis of our operating results that are prepared on an adjusted performance basis;
  • strategic plans and annual budgets are prepared on an adjusted performance basis; and
  • senior management’s annual compensation is calculated, in part, using adjusted performance measures.

Adjusted Operating Income

We define Adjusted Operating Income as operating income adjusted for the following:

  • Share-based compensation adjustment:
  • Following June 12, 2013, the effective date of the share-based compensation plan amendments, the share-based compensation expense adjustment represents the difference between equity plan accounting using the grant date fair value and equity plan accounting using the June 12, 2013 fair value. Prior to June 12, 2013, the share-based compensation expense adjustment represents the difference between share-based compensation expense accounted for under equity plan accounting based on grant date fair value, and under liability plan accounting based on reporting date fair value.
  • Future adjustments for share-based compensation will consist of the difference between expense under equity plan accounting based on the grant date fair value and total estimated share-based compensation expense, which is based on (i) the fair value on June 12, 2013 for nonqualified stock option awards and restricted stock units (“RSUs”) and (ii) all costs associated with the special incentive awards granted in fiscal 2012 and 2011. The estimated aggregate expense is approximately $5, $4, $1, and $0 for the fiscal years ended June 30, 2015, 2016, 2017, and 2018 respectively. Refer to “—Critical Accounting Policies and Estimates” in our Fiscal 2014 Form 10-K for a full discussion of the share-based compensation adjustment; and
  • Other adjustments, which include:
  • asset impairment charges;
  • restructuring costs and business structure realignment programs;
  • acquisition-related costs and certain acquisition accounting impacts; and
  • other adjustments that we believe investors may find useful.

Adjusted Net Income and Net Income per Common Share Attributable to Coty Inc.

We define Adjusted Net Income Attributable to Coty Inc. as net income attributable to Coty Inc. adjusted for the following:

  • adjustment made to reconcile operating income to Adjusted Operating Income, net of the income tax effect thereon (see Adjusted Operating Income);
  • certain interest, other (income) expense and other adjustments, net of the income tax effect thereon, that we do not consider indicative of our performance; and
  • certain tax effects that are not indicative of our performance.

Adjusted basic and diluted Net Income Attributable to Coty Inc. per Common Share is calculated as:

  • Adjusted Net Income Attributable to Coty Inc. divided by
  • Adjusted weighted-average basic and diluted common shares using the treasury stock method.

Constant Currency

We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations (“constant currency”). Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using constant foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.

Marketing and Advertising Costs

Marketing and advertising costs include the aggregate of trade marketing spend activities and advertising and consumer promotional costs, which are included as a reduction to gross revenues and in selling, general and administrative expenses, respectively, based on the counterparty. Marketing and advertising costs for the three and nine months ended March 31, 2015 and 2014 are presented below:

Three Months Ended March 31, 2015 2014 Nine Months Ended March 31, 2015 2014
Trade marketing spend activities $94.7 $102.8 $354.3 $372.5
% of Net revenues 10.1% 10.2% 10.5% 10.6%
Advertising and consumer promotional costs 221.3 256.8 751.6 795.5
% of Net revenues 23.7% 25.5% 22.3% 22.7%
Total marketing and advertising costs $316.0 $359.6 $1,105.9 $1,168.0
% of Net revenues 33.8% 35.6% 32.8% 33.3%

The decrease in advertising and consumer promotion spending primarily reflects the positive impact of foreign currency exchange translations and a focus on improving spend efficiency.

THREE MONTHS ENDED MARCH 31, 2015 AS COMPARED TO THREE MONTHS ENDED MARCH 31, 2014

NET REVENUES

In the three months ended March 31, 2015, net revenues decreased 7%, or $74.9, to $933.8 from $1,008.7 in the three months ended March 31, 2014. The decrease was primarily the result of a negative foreign currency exchange translations impact of 7% and a decrease in unit volume of 4%, partially offset by a positive price and mix impact of 4%. In fiscal 2014, we announced the discontinuation of our TJoy brand and the reorganization of our mass business in China (“China Optimization”). Excluding the negative impact of foreign currency exchange translations and the impact of the discontinuation of TJoy and China Optimization, total net revenues in the three months ended March 31, 2015 were consistent with total net revenues in the three months ended March 31, 2014, reflecting a positive price and mix impact of 3% and a decrease in unit volume of 3%. The impact to net revenues from the discontinuation of TJoy and China Optimization affected our Skin & Body Care segment in Asia Pacific, as discussed further below.

Net Revenues by Segment

(in millions)

NET REVENUES Three Months Ended March 31, 2015 2014 Change %
Fragrances $431.3 $476.1 (9%)
Color Cosmetics 336.6 344.9 (2%)
Skin & Body Care 165.9 187.7 (12%)
Total $933.8 $1,008.7 (7%)

Fragrances

In the three months ended March 31, 2015, net revenues of Fragrances decreased 9%, or $44.8, to $431.3 from $476.1 in the three months ended March 31, 2014. The decrease was primarily the result of a negative foreign currency exchange translations impact of 7% and a negative price and mix impact of 6%, partially offset by an increase in unit volume of 4%. Excluding the negative impact of foreign currency exchange translations, net revenues of Fragrances decreased 2%. The decrease in the segment reflects lower net revenues from power brands Calvin Klein, Davidoff and Marc Jacobs, as incremental net revenues from new launches could not offset the decline from existing product lines. Net revenues of power brand, Chloé, were negatively impacted by foreign currency exchange translations. Excluding the impact of foreign currency exchange translations, net revenues of Chloé increased primarily due to new launch Chloé Love Story. Partially offsetting the decrease in the segment were incremental net revenues resulting from a new commercial partnership with Avon in Brazil and the impact of retailer specific programs on certain brands in the U.S. The negative price and mix impact is primarily due to an ongoing increased level of promotional and discounted pricing activity, reflecting a competitive retail environment, and higher volumes of lower-priced fragrance products, in part as a result of expansion in Brazil and the types of products inherent in that expansion and retailer specific programs in the U.S.

Color Cosmetics

In the three months ended March 31, 2015, net revenues of Color Cosmetics decreased 2%, or $8.3, to $336.6 from $344.9 in the three months ended March 31, 2014. The decrease in the segment was primarily the result of a negative foreign currency exchange translations impact of 8% and a decrease in unit volume of 1%, partially offset by a positive price and mix impact of 7%. Excluding the negative impact of foreign currency exchange translations, net revenues of Color Cosmetics increased 6%. Growth in the segment was primarily driven by Sally Hansen, due to the success of new launch Sally Hansen Miracle Gel. Net revenues of Rimmel were negatively impacted by foreign currency exchange translations. Excluding the impact of foreign currency exchange translations, Rimmel had strong growth primarily due to new launches Rimmel Wonder'full mascara and Rimmel Provocalips liquid lipstick along with growth from existing products. Partially offsetting growth in the segment was lower net revenues from OPI, primarily driven by declining sales in the U.S., and Astor, primarily reflecting the negative impact of foreign currency exchange translations. The positive price and mix impact for the segment primarily reflects the launch of Sally Hansen Miracle Gel which positively contributed to the segment average price point and higher relative volumes of higher-priced OPI products.

Skin & Body Care

In the three months ended March 31, 2015, net revenues of Skin & Body Care decreased 12%, or $21.8, to $165.9 from $187.7 in the three months ended March 31, 2014. The decrease in the segment was primarily the result of a negative foreign currency exchange translations impact of 10% and a decrease in unit volume of 15%, partially offset by a positive price and mix impact of 13%. The discontinuation of TJoy and China Optimization positively impacted net revenues by 2%, contributing 5% to the unit volume decline while positively impacting price and mix by 7%. Excluding the impact to net revenues from the discontinuation of TJoy and China Optimization and the impact of foreign currency exchange translations, net revenues of Skin & Body Care decreased 4%. The decline in the segment was primarily driven by lower net revenues from adidas, Playboy and Lancaster. Lower net revenues from adidas in part reflect the negative impact of foreign currency exchange translations, a change in our distribution model from subsidiary to distributor in China, lower net revenues in the U.S. related to reduced shelf space at select retailers and a decline in net revenues in EMEA. The decrease in Playboy was primarily driven by the negative impact of foreign currency exchange translations and declining net revenues in existing product lines, partially offset by incremental net revenues from new launches such as Playboy #Generation for Him, Playboy #Generation for Her and Playboy Platinum. Results for Lancaster were negatively impacted by foreign currency exchange translations. Excluding the impact of foreign currency exchange translations, net revenues for Lancaster in the three months ended March 31, 2015 were in line with net revenues in the three months ended March 31, 2014. Partially offsetting the decline in the segment were higher net revenues from philosophy primarily reflecting strong growth in the U.S., due to increases in all key distribution channels, and in Asia Pacific. The positive price and mix impact for the segment primarily reflects higher relative volumes of higher-priced philosophy and Lancaster products compared to lower-priced adidas and Playboy products.

Net Revenues by Geographic Regions

In addition to our reporting segments, management also analyzes our net revenues by geographic region. We define our geographic regions as Americas (comprising North, Central and South America), EMEA (comprising Europe, the Middle East and Africa) and Asia Pacific (comprising Asia and Australia).

(in millions)

NET REVENUES Three Months Ended March 31, 2015 2014 Change %
Americas $394.8 $382.2 3%
EMEA 419.5 499.9 (16%)
Asia Pacific 119.5 126.6 (6%)
Total $933.8 $1,008.7 (7%)

Americas

In the three months ended March 31, 2015, net revenues in the Americas increased 3%, or $12.6, to $394.8 from $382.2 in the three months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations of 2%, net revenues in the Americas increased 5% primarily driven by higher net revenues in Brazil primarily as a result of our commercial partnership with Avon, and in the U.S. Growth in the U.S. was primarily driven by higher net revenues from Sally Hansen following the launch of Sally Hansen Miracle Gel, Rimmel and philosophy. Rimmel had strong growth primarily due to higher net revenues from Rimmel Moisture Renew lipstick, Rimmel Exaggerate eyeliner and lip pencils as well as from new launches Rimmel Provocalips liquid lipstick and Rimmel Wonder'full mascara. Higher net revenues from philosophy primarily reflect strong growth in the U.S., due to increases in net revenues in all key distribution channels. Also contributing to growth in the U.S. were higher net revenues due to the impact of retailer specific programs on certain brands in the Fragrances segment. Partially offsetting the increase in the U.S. were lower net revenues from OPI, reflecting declines in key distribution channels, and from N.Y.C. New York Color, adidas and Playboy primarily due to loss of shelf space at select retailers in the U.S. Partially offsetting growth in the region were lower net revenues in Canada, primarily in the Fragrances segment.

EMEA

In the three months ended March 31, 2015, net revenues in EMEA decreased 16%, or $80.4, to $419.5 from $499.9 in the three months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations, net revenues in EMEA decreased 3%, in part reflecting an ongoing increased level of promotional and discounted pricing activity. Net revenues in our travel retail business and Southern Europe declined, primarily driven by Fragrances in part due to lower net revenues from Calvin Klein and Davidoff. Lower net revenues in the U.K. were partially due to lower net revenues in Fragrances, primarily driven by Davidoff, and Skin & Body Care, in part driven by adidas, as partially offset by growth in Color Cosmetics. Lower net revenues in Germany were primarily driven by a decline in Fragrances and Playboy brand products. Net revenues in Eastern Europe declined due to the negative impact of foreign currency exchange translations. Excluding this impact, however, Eastern Europe generated growth primarily reflecting increased net revenues in Color Cosmetics, primarily driven by Rimmel and Sally Hansen. Partially offsetting the decline in the region were higher net revenues in the Middle East where we have benefited from our new K.S.A. joint venture.

Asia Pacific

In the three months ended March 31, 2015, net revenues in Asia Pacific decreased 6%, or $7.1, to $119.5 from $126.6 in the three months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations of 6% and the positive impact to net revenues from the TJoy discontinuation and China Optimization of 2%, net revenues in Asia Pacific decreased 2%. Results in the region were adversely impacted by lower net revenues in China which was primarily due to a decline in Calvin Klein, lower net revenues from adidas in part due to the change in our distribution model and by the discontinuation of TJoy. Lower net revenues in Hong Kong and Japan primarily reflect a decline in Fragrances. Net revenues in Australia were affected by the negative impact of foreign currency exchange translations. Excluding this impact, however, net revenues increased primarily due to growth in Fragrances, in part driven by higher net revenues from David Beckham and Calvin Klein. Contributing to growth in the region were higher net revenues in Southeast Asia, primarily due to adidas and Calvin Klein, and Korea, reflecting higher net revenues of Fragrances.

COST OF SALES

In the three months ended March 31, 2015, cost of sales decreased 11%, or $43.8, to $351.8 from $395.6 in the three months ended March 31, 2014. Cost of sales as a percentage of net revenues decreased to 37.7% in the three months ended March 31, 2015 from 39.2% in the three months ended March 31, 2014, resulting in a gross margin improvement of approximately 150 basis points. The increase in gross margin includes the positive impact from the refinement of estimates associated with China Optimization in the three months ended March 31, 2015 and the revaluation of acquired inventory through business acquisitions in the three months ended March 31, 2014. Excluding the impact of these items on net revenues and cost of sales, gross margin in the three months ended March 31, 2015 was consistent with gross margin in the three months ended March 31, 2014 primarily reflecting continued contribution from our supply chain savings program, reported in cost of sales, and the positive impact of foreign currency exchange translations, offset by the negative impact of higher customer discounts and allowances, reported in net revenues, and higher excess and obsolete inventory charges.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the three months ended March 31, 2015, selling, general and administrative expenses decreased 18%, or $97.9, to $445.3 from $543.2 in the three months ended March 31, 2014. Selling, general and administrative expenses as a percentage of net revenues decreased to 47.7% in the three months ended March 31, 2015 from 53.8% in the three months ended March 31, 2014. This decrease of approximately 610 basis points includes a reduction of approximately 320 basis points related to lower real estate consolidation program costs, China Optimization costs, share-based compensation expense adjustment and acquisition-related costs. See “Adjusted Operating Income.” Excluding the items described above and the impact to net revenues associated with China Optimization, selling, general and administrative expenses decreased 13%, or $66.1, to $452.7 from $518.8 in the three months ended March 31, 2014 and decreased as a percentage of net revenues to 48.8% from 51.4%. This decrease of approximately 260 basis points primarily reflects lower advertising and consumer promotion spending and lower administrative costs. The decrease in advertising and consumer promotion spending primarily reflects the positive impact of foreign currency exchange translations and a focus on improving spend efficiency. Lower administrative costs primarily reflect the positive impact of foreign currency exchange translations and costs savings resulting from our Organizational Redesign and China Optimization programs.

OPERATING INCOME

In the three months ended March 31, 2015, operating income increased $386.7, to $114.7 from $(272.0) in the three months ended March 31, 2014. Operating margin, or operating income as a percentage of net revenues, increased to 12.3% of net revenues in the three months ended March 31, 2015 as compared to (27.0%) in the three months ended March 31, 2014. This margin improvement primarily reflects the impact of lower asset impairment charges in our Skin & Body Care segment. Also contributing to the margin improvement was approximately 610 basis points related to lower selling, general and administrative expenses, approximately 150 basis points related to lower cost of sales and approximately 20 basis points related to lower amortization expense primarily due to the impairment of the TJoy trademark and customer relationships.

Operating Income by Segment

(in millions)

OPERATING INCOME (LOSS) Three Months Ended March 31, 2015 2014 Change %
Fragrances $59.0 $54.5 8%
Color Cosmetics 39.3 36.7 7%
Skin & Body Care 21.8 (326.7) >100%
Corporate (5.4) (36.5) 85%
Total $114.7 $(272.0) >100%

Fragrances

In the three months ended March 31, 2015, operating income for Fragrances increased 8%, or $4.5, to $59.0 from $54.5 in the three months ended March 31, 2014. Operating margin increased to 13.7% of net revenues in the three months ended March 31, 2015 as compared to 11.4% in the three months ended March 31, 2014, primarily driven by lower selling, general and administrative expenses as a percentage of net revenues, partially offset by higher cost of sales as a percentage of net revenues.

Color Cosmetics

In the three months ended March 31, 2015, operating income for Color Cosmetics increased 7%, or $2.6, to $39.3 from $36.7 in the three months ended March 31, 2014. Operating margin increased to 11.7% of net revenues in the three months ended March 31, 2015 as compared to 10.6% in the three months ended March 31, 2014, primarily reflecting lower cost of sales as a percentage of net revenues, partially offset by higher selling, general and administrative expenses as a percentage of net revenues.

Skin & Body Care

In the three months ended March 31, 2015, operating income for Skin & Body Care increased $348.5, to $21.8 from $(326.7) in the three months ended March 31, 2014, primarily reflecting asset impairment charges of $316.9 in the three months ended March 31, 2014. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. Also included in operating income in the three months ended March 31, 2015 is income of $19.4 related to China Optimization.

Excluding income related to China Optimization in the three months ended March 31, 2015 and asset impairment charges in the three months ended March 31, 2014, operating income increased $12.2, to $2.4 from $(9.8) in the three months ended March 31, 2014. Excluding net revenues and income related to China Optimization, operating margin increased to 1.5% of net revenues in the three months ended March 31, 2015 as compared to (5.2%) in the three months ended March 31, 2014, primarily driven by lower cost of sales, selling, general and administrative expenses and amortization expense as percentages of net revenues.

Corporate

Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the three months ended March 31, 2015, operating loss for Corporate was $5.4 compared to $36.5 in the three months ended March 31, 2014, as described under “Adjusted Operating Income” below.

Adjusted Operating Income

We believe that Adjusted Operating Income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to Adjusted Operating Income is presented below:

(in millions)

Three Months Ended March 31, 2015 2014 Change %
Reported Operating Income (Loss) $114.7 $(272.0) >100%
% of Net revenues 12.3% (27.0%)
Restructuring and other business realignment costs 7.7 7.3 5%
Acquisition-related costs 0.3 9.3 (97%)
Asset impairment charges — 316.9 (100%)
Real estate consolidation program costs — 13.4 (100%)
Share-based compensation (income)/expense adjustment (2.2) 6.5 <(100%)
China Optimization (19.6) — N/A
Total adjustments to Reported Operating Income (Loss) (13.8) 353.4 <(100%)
Adjusted Operating Income $100.9 $81.4 24%
% of Net revenues 10.8% 8.1%

In the three months ended March 31, 2015, Adjusted Operating Income increased 24%, or $19.5, to $100.9 from $81.4 in the three months ended March 31, 2014. Adjusted operating margin increased to 10.8% of net revenues in the three months ended March 31, 2015 as compared to 8.1% in the three months ended March 31, 2014, primarily reflecting lower selling, general and administrative expenses, as described under “Selling, General and Administrative Expenses” above. Excluding the impact of foreign currency exchange translations, Adjusted Operating Income increased 25%.

Restructuring and Other Business Realignment Costs

In the three months ended March 31, 2015, we incurred restructuring and other business structure realignment costs of $7.7, as follows:

  • We incurred restructuring costs of $4.3, included in restructuring costs in the Condensed Consolidated Statements of Operations, which primarily relates to the Organizational Redesign. These costs exclude $0.4 of income related to the refinement in estimates associated with China Optimization. See “China Optimization”.
  • We incurred business structure realignment costs of $3.4 primarily related to our Organizational Redesign and certain other programs, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the three months ended March 31, 2014, we incurred restructuring and other business structure realignment costs of $7.3, as follows:

  • We incurred restructuring costs of $3.9, included in restructuring costs in the Condensed Consolidated Statements of Operations, primarily related to the Productivity Program which targeted the integration of

supply chain and selling activities within the Skin & Body Care segment, as well as certain commercial organization re-design activities, primarily in Europe, productivity programs across our supply chain and optimization of selected administrative support functions.

  • We incurred business structure realignment costs of $3.4. These costs include $3.7 primarily related to certain other programs, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and $0.3 of income due to the change in estimates related to integration expenses, included in cost of sales in the Condensed Consolidated Statements of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

Acquisition-Related Costs

In the three months ended March 31, 2015, we incurred acquisition-related costs of $0.3 associated with a completed acquisition, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the three months ended March 31, 2014, we incurred acquisition-related costs of $9.3. These costs include $8.5 of costs primarily related to acquisition accounting impacts of revaluation of acquired inventory, included in cost of sales in the Condensed Consolidated Statements of Operations and $0.8 of costs which primarily consist of costs related to certain completed business combinations, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all acquisition-related costs were reported in Corporate.

Asset Impairment Charges

In the three months ended March 31, 2015, we did not incur any asset impairment charges.

In the three months ended March 31, 2014, we incurred asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. In the course of evaluating the results and preparing the financial statements for the three months ended March 31, 2014, we determined that net cash outflows associated with the TJoy mass channel business in China were significantly in excess of previous expectations in spite of a reorganization of our management team and distribution network and the launch of new product offerings through which we anticipated realizing significant improvements in cash flows beginning in the three months ended March 31, 2014.

Real Estate Consolidation Program Costs

In the three months ended March 31, 2015, we did not incur any costs in connection with the consolidation of real estate.

In the three months ended March 31, 2014, we incurred $13.4 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $12.6 of lease loss expense and $0.9 of duplicative rent expense recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all real estate consolidation program costs were included in Corporate.

Share-Based Compensation Adjustment

Share-based compensation (income)/expense adjustment included in the calculation of Adjusted Operating Income was $(2.2) and $6.5 in the three months ended March 31, 2015 and 2014, respectively. The decrease in the share-based compensation expense adjustment primarily reflects an increase in the actual and expected forfeiture rate reflecting the impact of our recent Organizational Redesign and the impact of the vesting of special incentive awards associated with our initial public offering.

Senior management evaluates operating performance of our segments based on the share-based expense calculated under equity plan accounting for the recurring stock option awards, share-based awards, and director-owned and employee-owned shares, and we follow the same treatment of the share-based compensation for the financial covenant compliance calculations under our debt agreements. See “Overview—Non-GAAP Financial Measures.” Share-based compensation expense calculated under equity plan accounting for the recurring nonqualified stock option awards and director-owned and employee-owned shares, restricted shares, and RSUs is reflected in the operating results of the segments. Share-based compensation adjustment is included in Corporate. See Note 3, “Segment Reporting” in our notes to the Condensed Consolidated Financial Statements.

China Optimization

In the three months ended March 31, 2015, we incurred income of $19.6 related to China Optimization, of which $8.9, $6.4, $3.9 and $0.4 was recorded in selling, general and administrative expenses, net revenues, cost of sales and restructuring costs in the Condensed Consolidated Statements of Operations, respectively. Income of $11.5 was restructuring related, primarily consisting of $5.3 due to the gain on sale of a facility and $5.7 due to a change in estimates related to inventory obsolescence and sales returns recorded in connection with the China Optimization at June 30, 2014. Income of $8.1 primarily reflects changes in estimates associated with pre-restructuring related activities. We primarily attribute the changes in estimates to the unanticipated sale of the TJoy brand and supporting production facility to a single buyer at the beginning of the third quarter, allowing the brand to remain viable in the marketplace. We believe that this resulted in lower than initially estimated returns, customer incentives payments and related costs. Income of $19.4 and $0.4 related to China Optimization was reported in the Skin & Body Care segment and Corporate, respectively, and costs of $0.2 related to China Optimization were reported in the Color Cosmetics segment.

INTEREST EXPENSE, NET

In the three months ended March 31, 2015, interest expense, net was $17.6 as compared with $17.3 in the three months ended March 31, 2014. This increase is primarily due to increased amortization of the deferred financing fees of $1.6 related to debt re-financing, partially offset by a benefit from foreign exchange, net of derivative foreign exchange contracts.

INCOME TAXES

The effective income tax rate for the three months ended March 31, 2015 and 2014 was 15.8% and 14.1%, respectively. The variation in the effective tax rate related to the three months ended March 31, 2015 was primarily due to the negative impact of a partial valuation allowance established for excess U.S. net deferred tax assets offset by the positive impacts of the decrease in the accrual for unrecognized tax benefits. The variation in the effective tax rate related to the three months ended March 31, 2014 was primarily due to the negative impact of asset impairment charges with minimal tax benefits and the positive effects of the reversal of certain previously unrecognized tax benefits approximating $38.1.

The effective rates vary from the U.S. federal statutory rate of 35% due to the effect of (1) jurisdictions with different statutory rates, (2) adjustments to our unrecognized tax benefits and accrued interest, (3) non-deductible expenses and (4) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

(in millions)

Three Months Ended March 31, 2015 Income Before Income Taxes Provision for Income Taxes Effective Tax Rate Three Months Ended March 31, 2014 Income Before Income Taxes Provision for Income Taxes Effective Tax Rate
Reported Income Before Income Taxes $97.6 $15.4 15.8% $(287.2) $(40.5) 14.1%
Adjustments to Reported Operating Income (Loss) (a) (13.8) (1.9) 353.4 13.4
Adjusted Income Before Income Taxes $83.8 $13.5 16.1% $66.2 $(27.1) (40.9%)

(a) See “Reconciliation of Operating Income to Adjusted Operating Income” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

The adjusted effective tax rate was 16.1% compared to (40.9%) in the prior-year period. The differences were primarily due to the negative impacts of the excess U.S. net deferred tax assets that cannot be realized offset by the positive impacts associated with a decrease in the accrual for unrecognized tax benefits. Cash paid during the quarter for income taxes of $13.2 and $9.6, represents 15.8% and 14.5% of Adjusted income before income taxes for the three months ended March 31, 2015 and 2014, respectively.

NET INCOME ATTRIBUTABLE TO COTY INC.

In the three months ended March 31, 2015, net income attributable to Coty Inc. increased $328.8, to $75.5, from $(253.3) in the three months ended March 31, 2014, primarily reflecting higher operating income.

We believe that Adjusted Net Income Attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

(in millions)

Three Months Ended March 31, 2015 2014 Change %
Reported Net Income (Loss) Attributable to Coty Inc. $75.5 $(253.3) >100%
% of Net revenues 8.1% (25.1%)
Adjustments to Reported Operating Income (Loss) (a) (13.8) 353.4 <(100%)
Change in tax provision due to adjustments to Reported Net Income (Loss) Attributable to Coty Inc. 1.9 (13.4) >100%
Adjusted Net Income Attributable to Coty Inc. $63.6 $86.7 (27%)
% of Net revenues 6.8% 8.6%
Per Share Data
Adjusted weighted-average common shares (b)
Basic 344.7 384.0
Diluted 354.8 392.0
Adjusted net income attributable to Coty Inc. per common share
Basic $0.18 $0.23
Diluted 0.18 0.22

(a) See “Reconciliation of Operating Income to Adjusted Operating Income” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

(b) In the three months ended March 31, 2015, the adjusted number of common shares used to calculate non-GAAP adjusted basic and diluted net income attributable to Coty Inc. per common share is identical to the number of common and diluted shares used to calculate GAAP net income (loss) per common share. In the three months ended March 31, 2014, using the treasury stock method, the number of adjusted diluted common shares to calculate non-GAAP adjusted diluted net income per common share was 8.0 million higher than the number of common shares used to calculate GAAP diluted net loss per common share, due to the potentially dilutive effect of certain securities issuable under our share-based compensation plans, which were considered anti-dilutive for calculating GAAP diluted net loss per common share.

NINE MONTHS ENDED MARCH 31, 2015 AS COMPARED TO NINE MONTHS ENDED MARCH 31, 2014

NET REVENUES

In the nine months ended March 31, 2015, net revenues decreased 4%, or $134.4, to $3,375.7 from $3,510.1 in the nine months ended March 31, 2014. The decrease was primarily the result of a negative foreign currency exchange translations impact of 4% and a decrease in unit volume of 1%, partially offset by a positive price and mix impact of 1%. In fiscal 2014, we announced the discontinuation of our TJoy brand and the reorganization of our mass business in China (“China Optimization”). Excluding the negative impact of foreign currency exchange translations and the discontinuation of TJoy and China Optimization, total net revenues and unit volume in the nine months ended March 31, 2015 were consistent with total net revenues and unit volume in the nine months ended March 31, 2014 and the price and mix had an immaterial impact on net revenues. The impact to net revenues from the discontinuation of TJoy and China Optimization negatively affected primarily our Skin & Body Care segment in Asia Pacific.

Net Revenues by Segment

(in millions)

NET REVENUES Nine Months Ended March 31, 2015 2014 Change %
Fragrances $1,763.9 $1,863.5 (5%)
Color Cosmetics 1,021.2 990.6 3%
Skin & Body Care 590.6 656.0 (10%)
Total $3,375.7 $3,510.1 (4%)

Fragrances

In the nine months ended March 31, 2015, net revenues of Fragrances decreased 5%, or $99.6, to $1,763.9 from $1,863.5 in the nine months ended March 31, 2014. The decrease was primarily the result of a negative price and mix impact of 8% and a negative foreign currency exchange translations impact of 3%, partially offset by an increase in unit volume of 6%. Excluding the negative impact of foreign currency exchange translations, net revenues of Fragrances decreased 2%. The decrease in the segment primarily reflects lower net revenues from existing celebrity brands that are later in their lifecycles and a decline in Roberto Cavalli and Davidoff, reflecting lower new launch activity in the nine months ended March 31, 2015 relative to the strong contribution from new launches in the nine months ended March 31, 2014. Results for Calvin Klein were negatively impacted by foreign currency exchange translations. Excluding the impact of foreign currency exchange translations, net revenues for Calvin Klein in the nine months ended March 31, 2015 were consistent with net revenues in the nine months ended March 31, 2014 as incremental net revenues from new launches were offset by declines from existing product lines. Partially offsetting the decrease in the segment were higher net revenues from power brands Chloé and Marc Jacobs in part due to the new launches of Chloé Love Story and Marc Jacobs Daisy Dream, along with incremental net revenues from recently launched Enrique Iglesias Adrenaline and Vespa and higher net revenues of David Beckham. The negative price and mix impact primarily reflects an ongoing increased level of promotional and discounted pricing activity, reflecting a competitive retail environment. Also contributing to the negative price and mix were higher relative volumes of lower-priced products sold in the mass retail channel in a certain emerging market, driven by a change in our distribution model.

Color Cosmetics

In the nine months ended March 31, 2015, net revenues of Color Cosmetics increased 3%, or $30.6, to $1,021.2 from $990.6 in the nine months ended March 31, 2014. The increase in the segment was primarily the result of a positive price and mix impact of 6% and an increase in unit volume of 1%, partially offset by a negative foreign currency exchange translations impact of 4%. Excluding the negative impact of foreign currency exchange translations, net revenues of Color Cosmetics increased 7%. Higher net revenues were primarily driven by strong growth in Rimmel and Sally Hansen. The increase in Rimmel primarily reflects incremental net revenues from new launches such as Rimmel Wonder'full mascara and Rimmel Provocalips liquid lipstick along with growth from existing brands, such as Rimmel Lasting Finish foundation. Higher net revenues from Sally Hansen were primarily driven by the success of new launch Sally Hansen Miracle Gel. Partially offsetting growth in the segment were lower net revenues from OPI, primarily driven by a decline in the U.S. partially offset by an increase in net revenues internationally, in part reflecting incremental net revenues following the acquisition of a U.K. distributor. The positive price and mix impact for the segment primarily reflects a price improvement in all major brands, in part reflecting the new launch of Sally Hansen Miracle Gel and a change in the OPI international distribution model in the U.K. and Australia.

Skin & Body Care

In the nine months ended March 31, 2015, net revenues of Skin & Body Care decreased 10%, or $65.4, to $590.6 from $656.0 in the nine months ended March 31, 2014. The decrease in the segment was primarily the result of a decline in unit volume of 9% and a negative foreign currency exchange translations impact of 5%, partially offset by a positive price and mix impact of 4%. The discontinuation of TJoy and China Optimization contributed 4% to the unit volume decline and positively impacted price and mix by 3%. Excluding the negative impact of foreign currency exchange translations and the impact to net revenues from the discontinuation of TJoy and China Optimization, net revenues of Skin & Body Care decreased 4% with a unit volume decline of 5% and a positive price and mix impact of 1%, primarily reflecting higher relative volumes of higher-priced products. The decrease in the segment was primarily driven by lower net revenues from adidas and Playboy. Lower net revenues from adidas in part reflect the negative impact of foreign currency exchange translations, a change in our distribution model from subsidiary to distributor in China, a decline in the U.S. primarily related to lower holiday orders and reduced shelf space at a key retailer in the nine months ended March 31, 2015 compared to the nine months ended March 31, 2014 and declining net revenues in existing product lines. Partially offsetting these declines in adidas were incremental net revenues in Brazil, due to the new commercial partnership with Avon, and incremental net revenues from new launches such as adidas UEFA Champions League Edition. The decline in Playboy was primarily driven by the negative impact of foreign currency exchange translations, declining net revenues in existing product lines and lower net revenues in the U.S. related to reduced shelf space at select retailers and lower holiday orders in the nine months ended March 31, 2015 compared to the nine months ended March 31, 2014, partially offset by incremental net revenues from new launches Playboy #Generation for Him, Playboy #Generation for Her, and Playboy VIP for Him Black and growth in Brazil, due to the new commercial partnership with Avon. Partially offsetting the decrease in the segment were higher net revenues from philosophy primarily reflecting higher net revenues in the U.S. retail channel and strong growth in Asia Pacific.

Net Revenues by Geographic Regions

In addition to our reporting segments, management also analyzes our net revenues by geographic region. We define our geographic regions as Americas (comprising North, Central and South America), EMEA (comprising Europe, the Middle East and Africa) and Asia Pacific (comprising Asia and Australia).

(in millions)

NET REVENUES Nine Months Ended March 31, 2015 2014 Change %
Americas $1,291.0 $1,312.1 (2%)
EMEA 1,668.9 1,769.6 (6%)
Asia Pacific 415.8 428.4 (3%)
Total $3,375.7 $3,510.1 (4%)

Americas

In the nine months ended March 31, 2015, net revenues in the Americas decreased 2%, or $21.1, to $1,291.0 from $1,312.1 in the nine months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations of 2%, net revenues in the Americas in the nine months ended March 31, 2015 were consistent with the nine months ended March 31, 2014. Results in the region primarily reflect lower net revenues in the U.S. and Canada, partially offset by strong growth in Brazil due to incremental net revenues resulting from the new commercial partnership with Avon. The decline in the U.S. was primarily driven by lower net revenues of Fragrances, in part due to lower net revenues from existing celebrity brands that are later in their lifecycles, lower net revenues of OPI, primarily reflecting a decline in the retail channel driven by lower net revenues of Nicole by OPI, and of adidas and Playboy, in part due to reduced shelf space at select retailers in the U.S. and lower holiday orders in the nine months ended March 31, 2015 compared to the nine months ended March 31, 2014. Partially offsetting the decline in the U.S. were higher net revenues of power brands Sally Hansen, Rimmel and philosophy. Lower net revenues in Canada were primarily driven by a decline in the Fragrances segment.

EMEA

In the nine months ended March 31, 2015, net revenues in EMEA decreased 6%, or $100.7, to $1,668.9 from $1,769.6 in the nine months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations of 7%, net revenues in EMEA increased 1%. Generating growth in the region was our subsidiary in South Africa and the Middle East, where we have benefited from our new U.A.E. and K.S.A. joint ventures. Net revenues in the U.K. increased primarily reflecting a strong increase in Color Cosmetics, driven by incremental net revenues from OPI due to the acquisition of a U.K. distributor and increased net revenues from Rimmel. Net revenues in Germany, Russia, and Eastern Europe declined due to the negative impact of foreign currency exchange translations. Excluding the impact of foreign currency exchange translations, net revenues in Germany were in line with the prior year and net revenues in Russia and Eastern Europe increased in part driven by growth in Color Cosmetics and Calvin Klein. Net revenues in Southern Europe declined, primarily reflecting the negative impact of foreign currency exchange translations, along with lower net revenues of Fragrances, in part driven by Roberto Cavalli and Calvin Klein, and adidas. Net revenues in our travel retail business declined primarily due to Calvin Klein and Davidoff.

Asia Pacific

In the nine months ended March 31, 2015, net revenues in Asia Pacific decreased 3%, or $12.6, to $415.8 from $428.4 in the nine months ended March 31, 2014. Excluding the negative impact of foreign currency exchange translations of 3% and the impact to net revenues from the discontinuation of TJoy and China Optimization of 1%, net revenues in Asia Pacific increased 1%. Net revenues in Australia were affected by the negative impact of foreign currency exchange translations. Excluding this impact, however, net revenues increased primarily due to strong growth in Color Cosmetics and Fragrances, primarily driven by David Beckham, Calvin Klein and Guess. Contributing to growth in the region were higher net revenues in Southeast Asia reflecting higher net revenues in all three segments, with OPI, adidas and philosophy driving the growth. Results in the region were adversely impacted by lower net revenues in China. The decline in China was primarily driven by lower net revenues from adidas, in part due to the change in our distribution model, Calvin Klein and by the discontinuation of TJoy.

COST OF SALES

In the nine months ended March 31, 2015, cost of sales decreased 5%, or $74.0, to $1,342.9 from $1,416.9 in the nine months ended March 31, 2014. Cost of sales as a percentage of net revenues decreased to 39.8% in the nine months ended March 31, 2015 from 40.4% in the nine months ended March 31, 2014, resulting in a gross margin improvement of approximately 60 basis points. The increase in gross margin includes the impact from the refinement of estimates associated with China Optimization in the nine months ended March 31, 2015 and lower charges associated with the revaluation of acquired inventory through business acquisitions in the nine months ended March 31, 2015 compared to the nine months ended March 31, 2014. Excluding the impact of these items on net revenues and cost of sales, gross margin improved approximately 20 basis points primarily reflecting continued contribution from our supply chain savings program, reported in cost of sales, and the positive impact of foreign currency exchange translations, partially offset by the negative impact of higher customer discounts and allowances, reported in net revenues.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the nine months ended March 31, 2015, selling, general and administrative expenses decreased 10%, or $160.2, to $1,502.4 from $1,662.6 in the nine months ended March 31, 2014. Selling, general and administrative expenses as a percentage of net revenues decreased to 44.5% in the nine months ended March 31, 2015 from 47.4% in the nine months ended March 31, 2014. This decrease of approximately 290 basis points includes a reduction of approximately 220 basis points primarily related to lower real estate consolidation program costs, share-based compensation expense adjustment, acquisition-related costs and China Optimization costs. See “Adjusted Operating Income.” Excluding the items described above and the impact to net revenues associated with China Optimization, selling, general and administrative expenses decreased 5%, or $84.8, to $1,501.7 from $1,586.5 in the nine months ended March 31, 2014 and decreased as a percentage of net revenues to 44.6% from 45.2%. This decrease of 60 basis points primarily reflects lower administrative costs and advertising and consumer promotion spending. Lower administrative costs primarily reflect the positive impact of foreign currency exchange translations, costs savings resulting from our Organizational Redesign and China Optimization programs and lower discretionary costs reflecting our focus on cost containment in developed markets, partially offset by higher accruals related to the management incentive program. Lower advertising and consumer promotion spending primarily reflects the positive impact of foreign currency exchange translations and a focus on improving spend efficiency behind our non-power brands. Advertising and consumer promotion spending on our power brands increased compared to the prior year period.

OPERATING INCOME

In the nine months ended March 31, 2015, operating income increased $381.4, to $418.5 from $37.1 in the nine months ended March 31, 2014. Operating margin, or operating income as a percentage of net revenues, increased to 12.4% in the nine months ended March 31, 2015 as compared to 1.1% in the nine months ended March 31, 2014 and primarily reflects the impact of lower asset impairment charges in our Skin & Body Care segment. Also contributing to the margin improvement was approximately 290 basis points related to lower selling, general and administrative expenses, approximately 60 basis points related to lower cost of sales and approximately 30 basis points related to lower amortization expense primarily due to the impairment of the TJoy trademark and customer relationships, partially offset by higher restructuring costs of approximately 140 basis points.

Operating Income by Segment

(in millions)

OPERATING INCOME (LOSS) Nine Months Ended March 31, 2015 2014 Change %
Fragrances $325.0 $333.7 (3%)
Color Cosmetics 121.8 107.2 14%
Skin & Body Care 40.6 (307.0) >100%
Corporate (68.9) (96.8) 29%
Total $418.5 $37.1 >100%

Fragrances

In the nine months ended March 31, 2015, operating income for Fragrances decreased 3%, or $8.7, to $325.0 from $333.7 in the nine months ended March 31, 2014. The decrease in operating income reflects lower net revenues. Operating margin increased to 18.4% of net revenues in the nine months ended March 31, 2015 as compared to 17.9% in the nine months ended March 31, 2014, primarily driven by lower selling, general and administrative expenses as a percentage of net revenues, partially offset by higher cost of sales as a percentage of net revenues.

Color Cosmetics

In the nine months ended March 31, 2015, operating income for Color Cosmetics increased 14%, or $14.6, to $121.8 from $107.2 in the nine months ended March 31, 2014. The increase in operating income primarily reflects higher net revenues and improvement in operating margin. Operating margin increased to 11.9% of net revenues in the nine months ended March 31, 2015 as compared to 10.8% in the nine months ended March 31, 2014, primarily reflecting lower cost of sales as a percentage of net revenues, partially offset by higher selling, general and administrative expenses as a percentage of net revenues.

Skin & Body Care

In the nine months ended March 31, 2015, operating income for Skin & Body Care increased $347.6, to $40.6 from $(307.0) in the nine months ended March 31, 2014 primarily reflecting asset impairment charges of $316.9 in the nine months ended March 31, 2014. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. Also included in operating income in the nine months ended March 31, 2015 is income of $17.7 related to China Optimization.

Excluding charges related to China Optimization in the nine months ended March 31, 2015 and asset impairment charges in the nine months ended March 31, 2014, operating income increased $13.0, to $22.9 from $9.9 in the nine months ended March 31, 2015. Operating margin increased to 3.9% of net revenues in the nine months ended March 31, 2015 as compared to 1.5% in the nine months ended March 31, 2015, primarily driven by lower selling, general and administrative expenses and amortization expense as percentages of net revenues, partially offset by higher cost of sales as a percentage of net revenues.

Corporate

Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the nine months ended March 31, 2015, operating loss for Corporate was $68.9 compared to $96.8 in the nine months ended March 31, 2014, as described under “Adjusted Operating Income” below.

Adjusted Operating Income

We believe that Adjusted Operating Income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to Adjusted Operating Income is presented below:

(in millions)

Nine Months Ended March 31, 2015 2014 Change %
Reported Operating Income $418.5 $37.1 >100%
% of Net revenues 12.4% 1.1%
Restructuring and other business realignment costs 64.2 16.5 >100%
Acquisition-related costs 5.3 26.8 (80%)
Share-based compensation expense adjustment 0.6 19.9 (97%)
Asset impairment charges — 316.9 (100%)
Public entity preparedness costs — 1.2 (100%)
Real estate consolidation program costs (0.7) 32.4 <(100%)
China Optimization (19.0) — N/A
Total adjustments to Reported Operating Income 50.4 413.7 (88%)
Adjusted Operating Income $468.9 $450.8 4%
% of Net revenues 13.9% 12.8%

In the nine months ended March 31, 2015, Adjusted Operating Income increased 4%, or $18.1, to $468.9 from $450.8 in the nine months ended March 31, 2014. Adjusted operating margin increased to 13.9% of net revenues in the nine months ended March 31, 2015 as compared to 12.8% in the nine months ended March 31, 2014, driven by lower selling, general and administrative expenses, as described under “Selling, General and Administrative Expenses” above, cost of sales and amortization expense. Excluding the impact of foreign currency exchange translations, Adjusted Operating Income increased 5%.

Restructuring and Other Business Realignment Costs

In the nine months ended March 31, 2015, we incurred restructuring and other business structure realignment costs of $64.2, as follows:

  • We incurred restructuring costs of $56.9, included in restructuring costs in the Condensed Consolidated Statements of Operations, which primarily relates to the Organizational Redesign. These costs exclude $0.5 of income related to the refinement in estimates associated with China Optimization. See “China Optimization”.
  • We incurred business structure realignment costs of $7.3 primarily related to our Organizational Redesign and certain other programs, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the nine months ended March 31, 2014, we incurred restructuring and other business structure realignment costs of $16.5, as follows:

  • We incurred restructuring costs of $10.2, included in restructuring costs in the Condensed Consolidated Statements of Operations, primarily related to the Productivity Program which targeted the integration of supply chain and selling activities within the Skin & Body Care segment, as well as certain commercial organization re-design activities, primarily in Europe, productivity programs across our supply chain and optimization of selected administrative support functions.
  • We incurred business structure realignment costs of $6.3 related to certain other programs, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

Acquisition-Related Costs

In the nine months ended March 31, 2015, we incurred costs of $5.3 related to acquisition accounting impacts of revaluation of acquired inventory of $3.4, included in cost of sales in the Condensed Consolidated Statements of Operations and transaction-related costs incurred in connection with a completed acquisition of $1.9, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the nine months ended March 31, 2014, we incurred acquisition-related costs of $26.8. These costs primarily include $15.2 of fees related to the termination of a pre-existing manufacturing and distribution contract in South Africa after forming our wholly owned subsidiary in South Africa and $1.1 of costs related to certain completed or contemplated business combinations, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations, and $10.5 of costs related to acquisition accounting impacts of revaluation of acquired inventory, included in cost of sales in the Condensed Consolidated Statements of Operations.

In all reported periods, all acquisition-related costs were reported in Corporate.

Share-Based Compensation Adjustment

Share-based compensation expense adjustment included in the calculation of Adjusted Operating Income was $0.6 and $19.9 in the nine months ended March 31, 2015 and 2014, respectively. The decrease in the share-based compensation expense adjustment primarily reflects an increase in the actual and expected forfeiture rate reflecting the impact of our recent Organizational Redesign and the impact of the vesting of special incentive awards associated with our initial public offering.

Senior management evaluates operating performance of our segments based on the share-based expense calculated under equity plan accounting for the recurring stock option awards, share-based awards, and director-owned and employee-owned shares, and we follow the same treatment of the share-based compensation for the financial covenant compliance calculations under our debt agreements. See “Overview—Non-GAAP Financial Measures.” Share-based compensation expense calculated under equity plan accounting for the recurring nonqualified stock option awards and director-owned and employee-owned shares, restricted shares, and RSUs is reflected in the operating results of the segments. Share-based compensation adjustment is included in Corporate. See Note 3, “Segment Reporting” in our notes to the Condensed Consolidated Financial Statements.

Asset Impairment Charges

In the nine months ended March 31, 2015, we did not incur any asset impairment charges.

In the nine months ended March 31, 2014, we incurred asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. In the course of evaluating the results and preparing the financial statements for the three months ended March 31, 2014, we determined that net cash outflows associated with the TJoy mass channel business in China were significantly in excess of previous expectations in spite of a reorganization of our management team and distribution network and the launch of new product offerings through which we anticipated realizing significant improvements in cash flows beginning in the three months ended March 31, 2014.

Public Entity Preparedness Costs

In the nine months ended March 31, 2014, we incurred public entity preparedness costs of $1.2 primarily consisting of a third party expense reimbursement to JAB Holdings II B.V., Berkshire Partners LLC and Rhône Capital L.L.C. as described in “Certain Relationships and Related Transaction, and Director Independence - Third Party Expenses” in Part III - Item 13 of our Annual Report on Form 10-K for the year ended June 30, 2013 and remaining miscellaneous costs associated with our initial public offering. Public entity preparedness costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

Real Estate Consolidation Program Costs

In the nine months ended March 31, 2015, we incurred $0.7 of income related to the refinement of lease loss expense estimates in connection with the consolidation of real estate in New York, recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the nine months ended March 31, 2014, we incurred $32.4 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $21.5 of lease loss expense, $5.0 of duplicative rent expense and $4.4 of depreciation, recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

In all reported periods, all real estate consolidation program costs were reported in Corporate.

China Optimization

In the nine months ended March 31, 2015, we incurred income of $19.0 related to China Optimization, of which $8.4, $7.1, $3.0 and $0.5 was recorded in selling, general and administrative expenses, net revenues, cost of sales and restructuring costs in the Condensed Consolidated Statements of Operations, respectively. Income of $11.5 was restructuring related, primarily consisting of $5.3 due to the gain on sale of a facility and $5.7 due to a change in estimates related to inventory obsolescence and sales returns recorded in connection with the China Optimization at June 30, 2014. Income of $7.5 primarily reflects changes in estimates associated with pre-restructuring related activities. We primarily attribute the changes in estimates to the unanticipated sale of the TJoy brand and supporting production facility to a single buyer at the beginning of the third quarter, allowing the brand to remain viable in the marketplace. We believe that this resulted in lower than initially estimated returns, customer incentives payments and related costs. Income of $17.7, $0.8 and $0.5 related to China Optimization was reported in the Skin & Body Care segment, Color Cosmetics segment and Corporate, respectively.

INTEREST EXPENSE, NET

In the nine months ended March 31, 2015, interest expense, net was $56.3 as compared with $51.4 in the nine months ended March 31, 2014. This increase is primarily due to increased amortization of the deferred fees of $2.2 related to debt re-financing, an overall increase of $1.1 in foreign exchange expense, net of derivative contracts, higher global borrowings incurring an additional $1.1 in interest expense and decreased interest income of $0.5.

LOSS ON EARLY EXTINGUISHMENT OF DEBT

In the nine months ended March 31, 2015, we incurred $88.8 in losses in the first quarter on the early extinguishment of debt in conjunction with the repurchase of our Senior Notes as described in “—Financial Condition—Liquidity and Capital Resources” below.

INCOME TAXES

The effective income tax rate for the nine months ended March 31, 2015 and 2014 was 14.5% and (328.3) %, respectively. The variation in the effective tax rates related to the nine months period ended March 31, 2015 was primarily due to the positive impacts of the decrease in the accrual for unrecognized tax benefits, partially offset by the negative impact of a partial valuation allowance established for excess U.S. net deferred tax assets. The variation in the effective tax rates related to the nine months period ended March 31, 2014 was primarily due to the negative impact related to asset impairment charges with minimal tax benefits.

The effective rates vary from the U.S. federal statutory rate of 35% due to the effect of (1) jurisdictions with different statutory rates, (2) adjustments to our unrecognized tax benefits and accrued interest, (3) non-deductible expenses and (4) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

(in millions)

Nine Months Ended March 31, 2015 Income Before Income Taxes Provision for Income Taxes Effective Tax Rate Nine Months Ended March 31, 2014 Income Before Income Taxes Provision for Income Taxes Effective Tax Rate
Reported Income Before Income Taxes $273.6 $39.8 14.5% $(12.0) $39.4 (328.3%)
Adjustments to Reported Operating Income (a) 50.4 7.1 413.7 30.1
Other adjustments (b) 88.8 12.6 — —
Adjusted Income Before Income Taxes $412.8 $59.5 14.4% $401.7 $69.5 17.3%

(a) See “Overview—Non-GAAP Financial Measures” for further information.

(b) See “Reconciliation of Net Income Attributable to Coty Inc. to Adjusted Net Income Attributable to Coty Inc.” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

The adjusted effective tax rate was 14.4% compared to 17.3% in the prior-year period. The differences were primarily due the positive impacts associated with the decrease in the accrual for unrecognized tax benefits offset by the negative impact associated with the excess U.S. net deferred tax assets that cannot be realized. Cash paid during the nine months ended March 31, 2015 and 2014, for income taxes of $83.2 and $59.3, represents 20.2% and 14.8% of Adjusted income before income taxes for the nine months ended, respectively.

NET INCOME ATTRIBUTABLE TO COTY INC.

In the nine months ended March 31, 2015, net income attributable to Coty Inc. increased $288.8, to $211.5, from $(77.3) in the nine months ended March 31, 2014, . This increase primarily reflects higher operating income, partially offset by loss on early extinguishment of debt and higher tax expense as described above.

We believe that Adjusted Net Income Attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

(in millions)

Nine Months Ended March 31, 2015 2014 Change %
Reported Net Income (Loss) Attributable to Coty Inc. $211.5 $(77.3) >100%
% of Net revenues 6.3% (2.2%)
Adjustments to Reported Operating Income (a) 50.4 413.7 (88%)
Loss on early extinguishment of debt (b) 88.8 — N/A
Adjustments to noncontrolling interest expense (c) (1.2) — N/A
Change in tax provision due to adjustments to Reported Net Income (Loss) Attributable to Coty Inc. (19.7) (30.1) 35%
Adjusted Net Income Attributable to Coty Inc. $329.8 $306.3 8%
% of Net revenues 9.8% 8.7%
Per Share Data
Adjusted weighted-average common shares (d)
Basic 350.9 384.1
Diluted 360.7 392.9
Adjusted net income attributable to Coty Inc. per common share
Basic $0.94 $0.80
Diluted 0.91 0.78

(a) See “Reconciliation of Operating Income to Adjusted Operating Income” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

(b) Loss on early extinguishment of debt associated with repurchase of our Senior Notes. Included in loss on early extinguishment of debt in the Condensed Consolidated Statements of Operations.

(c) Noncontrolling interest expense related to the revaluation of inventory buyback associated with the conversion from a distributor to subsidiary distribution model in a select emerging market. Included in net income attributable to noncontrolling interests in the Condensed Consolidated Statements of Operations.

(d) In the nine months ended March 31, 2015, the adjusted number of common shares used to calculate non-GAAP adjusted basic and diluted net income attributable to Coty Inc. per common share is identical to the number of common and diluted shares used to calculate GAAP net income (loss) per common share. In the nine months ended March 31, 2014, using the treasury stock method, the number of adjusted diluted common shares to calculate non-GAAP adjusted diluted net income per common share was 8.8 million higher than the number of common shares used to calculate GAAP diluted net loss per common share, due to the potentially dilutive effect of certain securities issuable under our share-based compensation plans, which were considered anti-dilutive for calculating GAAP diluted net loss per common share.

FINANCIAL CONDITION

LIQUIDITY AND CAPITAL RESOURCES

Overview

Our primary sources of funds include cash generated from operations, borrowings from issuance of debt and committed and uncommitted lines of credit provided by banks and lenders in the U.S. and abroad. As of March 31, 2015, we had cash and cash equivalents of $1,144.1 compared with $1,238.0 at June 30, 2014.

Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during our first fiscal quarter in anticipation of higher global sales during the second quarter and strong cash generation in the second fiscal quarter as a result of increased demand by retailers associated with the holiday season. Our principal uses of cash are to fund planned operating expenditures, capital expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. The working capital movements are based on the sourcing of materials related to the production of our Fragrances, Color Cosmetics, and Skin & Body Care products.

As a result of the cash on hand, our ability to generate cash from operations and through access to our revolving credit facility and other lending sources, we believe we have sufficient liquidity to meet our ongoing needs on both a near term and long-term basis.

Debt

March 31, 2015 June 30, 2014
Short-term debt $32.9 $18.8
Credit Agreement due April 2018 800.0 —
Coty Inc. Credit Facility due April 2018
Term Loan 1,675.0 1,875.0
Revolving Loan Facility 1,077.5 899.5
Senior Notes
5.12% Series A notes due June 2017 — 100.0
5.67% Series B notes due June 2020 — 225.0
5.82% Series C notes due June 2022 — 175.0
Other long-term debt and long-term capital lease obligations 1.0 0.2
Total debt 3,586.4 3,293.5
Less: Short-term debt and current portion of long-term debt (35.5) (33.4)
Total Long-term debt $3,550.9 $3,260.1

2015 Credit Agreement

On March 24, 2015, the Company entered into a Credit Agreement (the “2015 Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent, and the Bank of America, N.A., BNP Paribas, Credit Agriole Corporate & Investment Bank, ING Bank, N.V., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as syndication agents. The Company used the proceeds of the 2015 Credit Agreement to repay in full the indebtedness outstanding on its then-existing 2014 Credit Agreement, as defined below, and to repay $200.0 million of indebtedness outstanding on the existing Credit Agreement, dated April 2, 2013, as amended (the “2013 Credit Agreement"). The 2015 Credit Agreement provides for a term loan of $800.0 million (the “2015 Term Loan”), payable in full on March 31, 2018. The terms of the 2015 Term Loan are substantially the same as those of the term loan (the “2013 Term Loan”) existing under the 2013 Credit Agreement, after giving effect to the 2015 Amendment as discussed below.

Rates of interest on amounts borrowed under the 2015 Credit Agreement were based on the London Interbank Offered Rate (“LIBOR”), a qualified Eurocurrency LIBOR, an alternative base rate, or a qualified local currency rate, as applicable to the borrowings, plus applicable spreads determined by the consolidated leverage ratio. Applicable spreads on the borrowings under the 2015 Credit Agreement could range from 0.125% to 1.875% based on the Company’s consolidated leverage ratio, as defined in the 2015 Credit Agreement. The applicable spread under the 2015 Credit Agreement in effect as of March 31, 2015 was 1.625%. The 2015 Credit Agreement also contained affirmative and negative covenants that are substantially the same as those contained in the 2013 Credit Agreement, as amended, as discussed below. As of March 31, 2015, deferred financing fees of $3.1 were recorded in Other noncurrent assets in the Condensed Consolidated Balance Sheet. Additionally, during the three months ended March 31, 2015, the Company recorded a write-off of $0.9 of deferred financing fees related to the repayment of $200.0 million of indebtedness outstanding on the 2013 Credit Agreement.

Coty Inc. Credit Facility

On September 29, 2014, the Company entered into an Amendment (the “2014 Amendment”) to its existing 2013 Credit Agreement. The 2014 Amendment permits the Company to maintain a consolidated leverage ratio equal to or less than 4.5 to 1.0 for the 12-month period following an acquisition, as defined in the 2013 Credit Agreement. As of September 30, 2014, the Company recorded deferred financing fees of $3.1 in Other noncurrent assets in the Condensed Consolidated Balance Sheet in connection with the 2014 Amendment.

On March 24, 2015, the Company entered into a further amendment (“2015 Amendment”) to the 2013 Credit Agreement. The 2015 Amendment amends, among other things, the financial covenants in the 2013 Credit Agreement. After giving effect to the 2015 Amendment, the 2013 Credit Agreement permits Coty to maintain a quarterly base leverage ratio, as defined therein, equal to or less than 3.95 to 1.0 for each fiscal quarter through to December 31, 2015, subject to certain agreed step-downs thereafter. As of March 31, 2015, the Company recorded deferred financing fees of $3.1 in Other noncurrent assets in the Condensed Consolidated Balance Sheet in connection with the 2015 Amendment. As of March 31, 2015, the Company had $172.5 available for borrowings under the 2013 Credit Agreement.

2014 Credit Agreement

On September 29, 2014, the Company entered into a Credit Agreement (the “2014 Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent, and Bank of America, N.A., Morgan Stanley MUFG Loan Partners, LLC and Wells Fargo Bank, N.A., as syndication agents. The 2014 Credit Agreement provided for a term loan of $600.0 scheduled to expire on September 28, 2015 at which time it was payable in full. Rates of interest on amounts borrowed under the 2014 Credit Agreement were based on LIBOR, a qualified Eurocurrency LIBOR, an alternative base rate, or a qualified local currency rate, as applicable to the borrowings, plus applicable spreads determined by the consolidated leverage ratio. Applicable spreads on the borrowings under the 2014 Credit Agreement could have ranged from 0.0% to 1.75% based on the Company’s consolidated leverage ratio, as defined in the 2014 Credit Agreement. The Company used the borrowings under the 2014 Credit Agreement to prepay the outstanding principal amount of the Senior Notes, prior to their maturity date as described below. As of March 31, 2015, deferred financing fees of $1.9 were recorded in Prepaid expenses and other current assets in the Condensed Consolidated Balance Sheet.

Senior Notes

On September 29, 2014, the Company prepaid the Senior Notes. The prepayment included the principal amount of Senior Notes of $500.0, accrued interest of $8.0 and a make-whole amount of $84.6. In connection with the prepayment, the Company incurred a loss on early extinguishment of debt of $88.8, which included the make-whole amount and the write-off of $4.2 of deferred financing fees related to the Senior Notes.

As of March 31, 2015, the Company is in compliance with all financial covenants within the Agreements.

Cash Flows

Condensed Consolidated Statements of Cash Flows Data: (in millions) Nine Months Ended March 31, 2015 2014
Net cash provided by operating activities $388.2 $443.1
Net cash used in investing activities (151.2) (224.3)
Net cash used in financing activities (162.3) (32.6)

Net cash provided by operating activities

Net cash provided by operating activities was $388.2 and $443.1 for the nine months ended March 31, 2015 and 2014, respectively. The decrease in operating cash inflows of $54.9 is primarily due to an increase in net working capital of $80.5, partially offset by a decrease in cash outflows from noncurrent assets of $37.4 primarily driven by a one-time prepayment made to a licensor in the nine months ended March 31, 2014.

Net cash used in investing activities

Net cash used in investing activities was $151.2 and $224.3 for the nine months ended March 31, 2015 and 2014, respectively. The decrease in cash outflows of $73.1 is primarily driven by the prior year payment of $29.5 related to business combinations during the nine months ended March 31, 2014 compared to $0.6 in the current year, the cash receipt of $14.1 from the sale of TJoy assets during the nine months ended March 31, 2015 and lower capital expenditures of $30.2 during the nine months ended March 31, 2015.

Net cash used in financing activities

Net cash used in financing activities was $162.3 and $32.6 for the nine months ended March 31, 2015 and 2014, respectively. The increase in financing cash outflows of $129.7 during the nine months ended March 31, 2015 is primarily attributable to an increase in the repurchase of common stock of $237.2 and higher net payments on foreign currency contracts of $31.6. The net outflows were partially offset by net cash inflows of $99.4 from debt related transactions including $84.0 higher net proceeds from short-term debt borrowing on local lines of credit and revolving loan facilities and higher cash inflows of $44.8 from the issuance of common stock.

Series A Preferred Stock

Between April 15 and April 17, 2015, we executed and delivered subscription agreements with respect to the issuance and sale of an aggregate amount of 7.4 million shares of Series A Preferred Stock, $0.01 par value (the “Series A Preferred Stock”) for an aggregate purchase price of $0.1. The holder of any Series A Preferred Stock is not entitled to receive any dividends and has no voting rights except as required by law. Under the terms provided in the various subscription agreements, a holder of Series A Preferred Stock is typically entitled to exchange any or all “Series A Preferred Stock” that has vested subject to certain terms and conditions (the “Vested Series A Preferred Stock”) prior to varying dates specified in the subscription agreements, into, at the sole election of the Corporation, either: (i) an amount in cash payable in U.S. dollars per share so exchanged equal to (I) the fair market value of a share of Class A Common Stock of the Company on the date of conversion minus (II) an amount equal to the sum of an amount in U.S. Dollars specified in each subscription agreement (the “Cash Conversion Price”) plus the fair market value of a share of such Class A Common Stock on the grant date of such Vested Series A Preferred Stock, subject to adjustment from time to time (the “Share Conversion Price” and aggregated with the Cash Conversion Price, the “Conversion Price”) (such difference, the “Preferred Net Value”), or (ii) the number of shares of Class A Common Stock whose aggregate value, as measured by the fair market value of a share of such Class A Common Stock on the date of conversion, is equal to the Preferred Net Value. A portion of the issuances of the Series A Preferred Stock were made pursuant to, and are subject to, our Equity and Long-Term Incentive Plan, as described below.

Dividends

On September 16, 2014, we announced a cash dividend of $0.20 per share, or $71.9 on our Class A and Class B Common Stock. Of the $71.9, $71.0 was paid on October 15, 2014 to holders of record of Class A and Class B Common Stock on October 1, 2014 and was recorded as a decrease to Additional Paid-in Capital (“APIC”) in the Condensed Consolidated Balance Sheet as of March 31, 2015. The remaining $0.9 is payable upon settlement of RSUs outstanding as of October 1, 2014, and is recorded as Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.

Additionally, we reduced the dividend accrual recorded in a prior period by $0.3 to adjust for accrued dividends on RSUs no longer expected to vest, which was recorded as an increase to APIC in the Condensed Consolidated Balance Sheet as of March 31, 2015. Total accrued dividends on unvested RSUs of $1.4 are included in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet as of March 31, 2015.

Share Repurchase

In connection with our Class A Common Stock repurchase program announced on February 14, 2014 and June 3, 2014, we repurchased 5.8 million and 13.4 million shares of our Class A Common Stock during the three and nine months ended March 31, 2015. The shares were purchased in multiple transactions at prices ranging from $18.64 to $21.99 during the three months ended, and $18.30 to $21.99 during the nine months ended March 31, 2015. The fair value of all shares repurchased was $113.9 and $263.1 during the three and nine months ended March 31, 2015 and was reflected as an increase to Treasury stock in our Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Equity and Redeemable Noncontrolling Interests.

On September 29, 2014, we entered into an agreement with Mr. Scannavini, our former Chief Executive Officer in connection with his resignation. The agreement required that we purchase on or before January 27, 2015 all Class A Common Stock Mr. Scannavini held directly or indirectly, including shares of Class A Common Stock obtained upon the exercise of certain stock options, for a share price of $17.21, which is the average closing value of the Class A Common Stock on the New York Stock Exchange over five business days immediately preceding September 29, 2014. As a result of the agreement, we purchased 2.4 million shares of its Class A Common Stock for $42.0 and reflected as an increase to Treasury stock in our

Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Equity and Redeemable Noncontrolling Interests during the nine months ended March 30, 2014. The Company made a net payment to Mr. Scannavini of $29.5, which is the purchase amount of $42.0 net of the aggregate exercise price of his vested stock options of $12.5.

Commitments and Contingencies

We have the right to purchase the noncontrolling interests in certain subsidiaries from the noncontrolling interest holders (each such right, a “Call right”) at certain points in time. In December 2014, we gave notice to exercise our Call right for 14% of a certain Singapore subsidiary from the noncontrolling interest at an estimated amount of approximately $12.8 for this 14%.

On April 1, 2015, we completed our previously announced purchase of 100% of the net assets of the Bourjois cosmetics brand (“Bourjois”) from Chanel International B.V. (“CHANEL”) pursuant to the Stock Purchase Agreement, dated as of March 12, 2015, between our company and CHANEL (the “Stock Purchase Agreement”), in order to further grow our existing portfolio and strengthen our position in the Color Cosmetics segment. We issued to our foreign subsidiaries 15.4 million shares of our Class A Common Stock for $373.5 in cash and subsequently exchanged these shares with CHANEL, as consideration for Bourjois. The shares had an approximately value of $373.5 based on the closing value of our Class A Common Stock on the New York Stock Exchange on April 1, 2015. We used the cash proceeds from our foreign subsidiaries to repay revolving debt, reducing total debt from approximately $3,600.0 as of March 31, 2015 to $3,200.0 as of April 2, 2015. As of the date of this Quarterly Report on Form 10-Q, the purchase price and purchase price allocation has not been completed as we are in the process of gathering the data required to perform the purchase price allocation. The purchase price and allocation are expected to be finalized during fiscal 2016.

Off-Balance Sheet Arrangements

We had undrawn letters of credit of $4.1 and $3.6 as of March 31, 2015 and June 30, 2014, respectively.

Critical Accounting Policies

We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our condensed consolidated financial statements.

  • Revenue Recognition
  • Goodwill, Other Intangible Assets and Long-Lived Assets
  • Pension and Other Post-Employment Benefit Costs
  • Share-Based Compensation
  • Income Taxes

As of March 31, 2015, there have been no material changes to the items disclosed as critical accounting policies and estimates in “Management Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2014 Form 10-K, aside from the changes in our Segments as discussed in Note 3, “Segment Reporting” in our notes to Condensed Consolidated Financial Statements.

Forward Looking Statements

Certain statements in this Quarterly Report on Form 10-Q are forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, our future operations and financial performance; expected growth; our ability to support our planned business operation on a near- and long-term basis. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “target”, “aim” and similar words or phrases.

Reported results should not be considered an indication of future performance, and actual results may differ materially from the results predicted due to risks and uncertainties including:

  • our ability to achieve our global business strategy and compete effectively in the beauty industry;
  • our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products;
  • our ability to identify suitable acquisition targets and managerial, integration, operational and financial risks associated with those acquisitions, including our recent acquisition of Bourjois;
  • risks related to our international operations, including reputational, regulatory, economic and foreign political risks, such as the political instability in Eastern Europe and the Middle East, the debt crisis and the economic environment in Europe and fluctuations in currency exchange rates;
  • dependence on certain licenses, entities performing outsourced functions and third-party suppliers;
  • our and our brand partners’ and licensors’ ability to obtain, maintain and protect the intellectual property rights used in our products and our abilities to protect our respective reputations;
  • our ability to implement the Organizational Redesign restructuring program as planned and the success of the program in delivering anticipated improvements and efficiencies;
  • administrative, development and other difficulties in meeting the expected timing of market expansions, product launches and marketing efforts;
  • global political and/or economic uncertainties or disruptions, including a general economic downturn, a sudden disruption in business conditions affecting consumer purchases of our products and volatility in the financial markets;
  • our ability to manage seasonal variability;
  • consolidation among retailers, shifts in consumers’ preferred distribution channels, and other changes in the retail environment in which we sell our products;
  • disruptions in operations;
  • increasing dependency on information technology and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches;
  • changes in laws, regulations and policies that affect our business or products;
  • market acceptance of new product introductions; and
  • the illegal distribution and sale by third parties of counterfeit versions of our products.

More information about potential risks and uncertainties that could affect our business and financial results is included under Item 1A. Risk Factors in our Fiscal 2014 Form 10-K.

We assume no responsibility to update forward-looking statements made herein or otherwise.

Industry, Ranking and Market Data

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the market in which we operate, including our general expectations about our industry, market position, market opportunity and market size, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public such as independent industry publications (including Euromonitor International Ltd), government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be generally reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.

We refer to North America, Western Europe and Japan as “developed markets,” and all other markets as “emerging markets”. We define North America as the United States of America and Canada. Except as specifically indicated, all references to rankings are based on retail value market share.

Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2015” refer to the fiscal year ended June 30, 2015. Any reference to a year not preceded by “fiscal” refers to a calendar year.

Market risk

As filed, 181 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2014 Form 10-K.

Controls and procedures

As filed, 3,560 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our interim Chief Executive Officer (the “ interim CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2015. Based on the evaluation of our disclosure controls and procedures as of March 31, 2015, our interim CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the third fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our interim CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$933.8mus-gaap:SalesRevenueGoodsNet
Revenue9 months2014-07-01 to 2015-03-31$3.38bnus-gaap:SalesRevenueGoodsNet
Cost of revenue3 months2015-01-01 to 2015-03-31$351.8mus-gaap:CostOfGoodsSold
Cost of revenue9 months2014-07-01 to 2015-03-31$1.34bnus-gaap:CostOfGoodsSold
Gross profit3 months2015-01-01 to 2015-03-31$582.0mus-gaap:GrossProfit
Gross profit9 months2014-07-01 to 2015-03-31$2.03bnus-gaap:GrossProfit
Selling, general and administrative3 months2015-01-01 to 2015-03-31$445.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2014-07-01 to 2015-03-31$1.50bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-01-01 to 2015-03-31$114.7mus-gaap:OperatingIncomeLoss
Operating income9 months2014-07-01 to 2015-03-31$418.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31$18.4mus-gaap:InterestExpense
Interest expense9 months2014-07-01 to 2015-03-31$55.2mus-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31$15.4mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2014-07-01 to 2015-03-31$39.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31$75.5mus-gaap:NetIncomeLoss
Net income9 months2014-07-01 to 2015-03-31$211.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.21us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2014-07-01 to 2015-03-31$0.59us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-01-01 to 2015-03-31$0.22us-gaap:EarningsPerShareBasic
Basic EPS9 months2014-07-01 to 2015-03-31$0.60us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-01-01 to 2015-03-31354,800,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2014-07-01 to 2015-03-31360,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2014-07-01 to 2015-03-31$388.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2014-07-01 to 2015-03-31$135.0mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases9 months2014-07-01 to 2015-03-31$263.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-03-31$1.14bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$2.50bnus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$6.11bnus-gaap:Assets
Current liabilitiesAt period end2015-03-31$1.29bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$5.49bnus-gaap:Liabilities
Long-term debtAt period end2015-03-31$3.55bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2015-03-31$35.5mus-gaap:DebtCurrent
Short-term borrowingsAt period end2015-03-31$32.9mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2015-03-31$503.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001024305-15-000032. Last ingested by Listed: Nov 11, 2026, 03:30 ET. Listed shows no prices and gives no investment advice.